Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) Interest & Investment Income (2018 - 2022)

Historic Interest & Investment Income for Serina Therapeutics (SER) over the last 5 years, with Q2 2022 value amounting to -$863000.0.

  • Serina Therapeutics' Interest & Investment Income fell 21496.35% to -$863000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was -$2.0 million, marking a year-over-year decrease of 14382.57%. This contributed to the annual value of -$1.1 million for FY2021, which is 17153.47% down from last year.
  • Latest data reveals that Serina Therapeutics reported Interest & Investment Income of -$863000.0 as of Q2 2022, which was down 21496.35% from -$571000.0 recorded in Q1 2022.
  • In the past 5 years, Serina Therapeutics' Interest & Investment Income registered a high of $39000.0 during Q3 2018, and its lowest value of -$863000.0 during Q2 2022.
  • Moreover, its 5-year median value for Interest & Investment Income was -$47500.0 (2020), whereas its average is -$155000.0.
  • In the last 5 years, Serina Therapeutics' Interest & Investment Income soared by 2222.22% in 2019 and then crashed by 168750.0% in 2020.
  • Quarter analysis of 5 years shows Serina Therapeutics' Interest & Investment Income stood at $32000.0 in 2018, then plummeted by 175.0% to -$24000.0 in 2019, then tumbled by 658.33% to -$182000.0 in 2020, then plummeted by 62.09% to -$295000.0 in 2021, then plummeted by 192.54% to -$863000.0 in 2022.
  • Its Interest & Investment Income was -$863000.0 in Q2 2022, compared to -$571000.0 in Q1 2022 and -$295000.0 in Q4 2021.